{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:20:27Z","timestamp":1793665227151,"version":"4.5.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8023","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.1038\/s41586-024-07710-8","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T12:01:38Z","timestamp":1721217698000},"page":"192-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Split intein-mediated protein trans-splicing to express large dystrophins"],"prefix":"10.1038","volume":"632","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1902-606X","authenticated-orcid":false,"given":"Hichem","family":"Tasfaout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Halbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"McMillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore R.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina V.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6227-5665","authenticated-orcid":false,"given":"Dirk","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Hauschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Regnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-0059","authenticated-orcid":false,"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"7710_CR1","first-page":"255","volume":"21","author":"CW Li","year":"2020","unstructured":"Li, C. W. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255\u2013272 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"7710_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","volume":"12","author":"SS Issa","year":"2023","unstructured":"Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V. & Rizvanov, A. A. Various AAV serotypes and their applications in gene therapy: an overview. Cells 12, 785 (2023).","journal-title":"Cells"},{"key":"7710_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/jvi.45.2.555-564.1983","volume":"45","author":"A Srivastava","year":"1983","unstructured":"Srivastava, A., Lusby, E. W. & Berns, K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555\u2013564 (1983).","journal-title":"J. Virol."},{"key":"7710_CR4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19230-w","volume":"11","author":"J Weinmann","year":"2020","unstructured":"Weinmann, J. et al. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat. Commun. 11, 5432 (2020).","journal-title":"Nat. Commun."},{"key":"7710_CR5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/316842a0","volume":"316","author":"AP Monaco","year":"1985","unstructured":"Monaco, A. P. et al. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 316, 842\u2013845 (1985).","journal-title":"Nature"},{"key":"7710_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/322073a0","volume":"322","author":"LM Kunkel","year":"1986","unstructured":"Kunkel, L. M. et al. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 322, 73\u201377 (1986).","journal-title":"Nature"},{"key":"7710_CR7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1096\/fj.01-0030fje","volume":"15","author":"G Danialou","year":"2001","unstructured":"Danialou, G. et al. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 15, 1655\u20131657 (2001).","journal-title":"FASEB J."},{"key":"7710_CR8","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. & Sweeney, H. L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA 90, 3710\u20133714 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7710_CR9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","volume":"66","author":"JM Ervasti","year":"1991","unstructured":"Ervasti, J. M. & Campbell, K. P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121\u20131131 (1991).","journal-title":"Cell"},{"key":"7710_CR10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti, J. M. & Campbell, K. P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809\u2013823 (1993).","journal-title":"J. Cell Biol."},{"key":"7710_CR11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AEH Emery","year":"2002","unstructured":"Emery, A. E. H. The muscular dystrophies. Lancet 359, 687\u2013695 (2002).","journal-title":"Lancet"},{"key":"7710_CR12","doi-asserted-by":"crossref","first-page":"e1000958","DOI":"10.1371\/journal.pgen.1000958","volume":"6","author":"GB Banks","year":"2010","unstructured":"Banks, G. B., Judge, L. M., Allen, J. M. & Chamberlain, J. S. The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins. PLoS Genet. 6, e1000958 (2010).","journal-title":"PLoS Genet."},{"key":"7710_CR13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","volume":"12","author":"P Gregorevic","year":"2006","unstructured":"Gregorevic, P. et al. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat. Med. 12, 787\u2013789 (2006).","journal-title":"Nat. Med."},{"key":"7710_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","volume":"27","author":"JN Ramos","year":"2019","unstructured":"Ramos, J. N. et al. Development of novel micro-dystrophins with enhanced functionality. Mol. Ther. 27, 623\u2013635 (2019).","journal-title":"Mol. Ther."},{"key":"7710_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","volume":"53","author":"B Bostick","year":"2012","unstructured":"Bostick, B. et al. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J. Mol. Cell. Cardiol. 53, 217\u2013222 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"7710_CR16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","volume":"8","author":"SQ Harper","year":"2002","unstructured":"Harper, S. Q. et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8, 253\u2013261 (2002).","journal-title":"Nat. Med."},{"key":"7710_CR17","doi-asserted-by":"publisher","unstructured":"Wasala, L. P. et al. The implication of hinge 1 and hinge 4 in micro-dystrophin gene therapy for Duchenne muscular dystrophy. Hum. Gene Ther. https:\/\/doi.org\/10.1089\/hum.2022.180 (2022).","DOI":"10.1089\/hum.2022.180"},{"key":"7710_CR18","doi-asserted-by":"crossref","first-page":"eabo1815","DOI":"10.1126\/scitranslmed.abo1815","volume":"15","author":"SM Birch","year":"2023","unstructured":"Birch, S. M. et al. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Sci. Transl. Med. 15, eabo1815 (2023).","journal-title":"Sci. Transl. Med."},{"key":"7710_CR19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/hum.2013.164","volume":"25","author":"T Koo","year":"2014","unstructured":"Koo, T., Popplewell, L., Athanasopoulos, T. & Dickson, G. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Hum. Gene Ther. 25, 98\u2013108 (2014).","journal-title":"Hum. Gene Ther."},{"key":"7710_CR20","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1153","volume":"23","author":"Y Lai","year":"2005","unstructured":"Lai, Y. et al. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol. 23, 1435\u20131439 (2005).","journal-title":"Nat. Biotechnol."},{"key":"7710_CR21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/hum.2013.210","volume":"25","author":"W Lostal","year":"2014","unstructured":"Lostal, W., Kodippili, K., Yue, Y. P. & Duan, D. S. Full-length dystrophin reconstitution with adeno-associated viral vectors. Hum. Gene Ther. 25, 552\u2013562 (2014).","journal-title":"Hum. Gene Ther."},{"key":"7710_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/mt.2010.205","volume":"19","author":"GL Odom","year":"2011","unstructured":"Odom, G. L., Gregorevic, P., Allen, J. M. & Chamberlain, J. S. Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Mol. Ther. 19, 36\u201345 (2011).","journal-title":"Mol. Ther."},{"key":"7710_CR23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1039\/C3SC52951G","volume":"5","author":"NH Shah","year":"2014","unstructured":"Shah, N. H. & Muir, T. W. Inteins: nature\u2019s gift to protein chemists. Chem. Sci. 5, 446\u2013461 (2014).","journal-title":"Chem. Sci."},{"key":"7710_CR24","doi-asserted-by":"crossref","first-page":"e15199","DOI":"10.15252\/emmm.202115199","volume":"14","author":"F Esposito","year":"2022","unstructured":"Esposito, F. et al. Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A. EMBO Mol. Med. 14, e15199 (2022).","journal-title":"EMBO Mol. Med."},{"key":"7710_CR25","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s10529-015-1905-2","volume":"37","author":"YF Li","year":"2015","unstructured":"Li, Y. F. Split-inteins and their bioapplications. Biotechnol. Lett 37, 2121\u20132137 (2015).","journal-title":"Biotechnol. Lett"},{"key":"7710_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.omtm.2022.08.004","volume":"26","author":"A Padula","year":"2022","unstructured":"Padula, A. et al. Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice. Mol. Ther. Methods Clin. Dev. 26, 495\u2013504 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"7710_CR27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.omtm.2021.10.004","volume":"23","author":"P Tornabene","year":"2021","unstructured":"Tornabene, P. et al. Inclusion of a degron reduces levels of undesired inteins after AAV-mediated protein trans-splicing in the retina. Mol. Ther. Methods Clin. Dev. 23, 448\u2013459 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"7710_CR28","doi-asserted-by":"crossref","first-page":"eaav4523","DOI":"10.1126\/scitranslmed.aav4523","volume":"11","author":"P Tornabene","year":"2019","unstructured":"Tornabene, P. et al. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci. Transl. Med. 11, eaav4523 (2019).","journal-title":"Sci. Transl. Med."},{"key":"7710_CR29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/hum.2008.009","volume":"19","author":"J Li","year":"2008","unstructured":"Li, J., Sun, W. C., Wang, B., Xiao, X. & Liu, X. Q. Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. Hum. Gene Ther. 19, 958\u2013964 (2008).","journal-title":"Hum. Gene Ther."},{"key":"7710_CR30","doi-asserted-by":"crossref","first-page":"28686","DOI":"10.1074\/jbc.M112.372680","volume":"287","author":"P Carvajal-Vallejos","year":"2012","unstructured":"Carvajal-Vallejos, P., Palliss\u00e9, R., Mootz, H. D. & Schmidt, S. R. Unprecedented rates and efficiencies revealed for new natural split inteins from metagenomic sources. J. Biol. Chem. 287, 28686\u201328696 (2012).","journal-title":"J. Biol. Chem."},{"key":"7710_CR31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1046\/j.1365-2958.2003.03825.x","volume":"50","author":"J Caspi","year":"2003","unstructured":"Caspi, J., Amitai, G., Belenkiy, O. & Pietrokovski, S. Distribution of split DnaE inteins in cyanobacteria. Mol. Microbiol. 50, 1569\u20131577 (2003).","journal-title":"Mol. Microbiol."},{"key":"7710_CR32","doi-asserted-by":"crossref","first-page":"11338","DOI":"10.1021\/ja303226x","volume":"134","author":"NH Shah","year":"2012","unstructured":"Shah, N. H., Dann, G. P., Vila-Perell\u00f3, M., Liu, Z. H. & Muir, T. W. Ultrafast protein splicing is common among cyanobacterial split inteins: implications for protein engineering. J. Am. Chem. Soc. 134, 11338\u201311341 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"7710_CR33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/nar\/26.2.623","volume":"26","author":"MR Abedi","year":"1998","unstructured":"Abedi, M. R., Caponigro, G. & Kamb, A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res. 26, 623\u2013630 (1998).","journal-title":"Nucleic Acids Res."},{"key":"7710_CR34","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","volume":"28","author":"JM Crudele","year":"2019","unstructured":"Crudele, J. M. & Chamberlain, J. S. AAV-based gene therapies for the muscular dystrophies. Hum. Mol. Genet. 28, R102\u2013R107 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"7710_CR35","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0960-8966(02)00092-5","volume":"12","author":"JM Boer","year":"2002","unstructured":"Boer, J. M., de Meijer, E. J., Mank, E. M., van Ommen, G. B. & den Dunnen, J. T. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mice. Neuromuscul. Disord. 12, S118\u2013S124 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"7710_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/110.2.269","volume":"110","author":"LFB Torres","year":"1987","unstructured":"Torres, L. F. B. & Duchen, L. W. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110, 269\u2013299 (1987).","journal-title":"Brain"},{"key":"7710_CR37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ymthe.2020.11.003","volume":"29","author":"NE Bengtsson","year":"2021","unstructured":"Bengtsson, N. E., Tasfaout, H., Hauschka, S. D. & Chamberlain, J. S. Dystrophin gene-editing stability is dependent on dystrophin levels in skeletal but not cardiac muscles. Mol. Ther. 29, 1070\u20131085 (2021).","journal-title":"Mol. Ther."},{"key":"7710_CR38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-7793.2001.00591.x","volume":"535","author":"GS Lynch","year":"2001","unstructured":"Lynch, G. S., Hinkle, R. T., Chamberlain, J. S., Brooks, S. V. & Faulkner, J. A. Force and power output of fast and slow skeletal muscles from mdx mice 6\u201328 months old. J. Physiol. 535, 591\u2013600 (2001).","journal-title":"J. Physiol."},{"key":"7710_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","volume":"129","author":"C Pastoret","year":"1995","unstructured":"Pastoret, C. & Sebille, A. Mdx mice show progressive weakness and muscle deterioration with age. J. Neurol. Sci. 129, 97\u2013105 (1995).","journal-title":"J. Neurol. Sci."},{"key":"7710_CR40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","volume":"352","author":"HH Stedman","year":"1991","unstructured":"Stedman, H. H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536\u2013539 (1991).","journal-title":"Nature"},{"key":"7710_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ar.1092420109","volume":"242","author":"JP Lefaucheur","year":"1995","unstructured":"Lefaucheur, J. P., Pastoret, C. & Sebille, A. Phenotype of dystrophinopathy in old mdx mice. Anat. Rec. 242, 70\u201376 (1995).","journal-title":"Anat. Rec."},{"key":"7710_CR42","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","volume":"21","author":"JS Chamberlain","year":"2007","unstructured":"Chamberlain, J. S., Metzger, J., Reyes, M., Townsend, D. W. & Faulkner, J. A. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 21, 2195\u20132204 (2007).","journal-title":"FASEB J."},{"key":"7710_CR43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","volume":"343","author":"SB England","year":"1990","unstructured":"England, S. B. et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343, 180\u2013182 (1990).","journal-title":"Nature"},{"key":"7710_CR44","doi-asserted-by":"crossref","first-page":"eabn4704","DOI":"10.1126\/sciadv.abn4704","volume":"8","author":"J El Andari","year":"2022","unstructured":"El Andari, J. et al. Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders. Sci. Adv. 8, eabn4704 (2022).","journal-title":"Sci. Adv."},{"key":"7710_CR45","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","volume":"184","author":"M Tabebordbar","year":"2021","unstructured":"Tabebordbar, M. et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184, 4919\u20134938.e22 (2021).","journal-title":"Cell"},{"key":"7710_CR46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/mthe.2001.0496","volume":"4","author":"D Hartigan-O\u2019Connor","year":"2001","unstructured":"Hartigan-O\u2019Connor, D., Kirk, C. J., Crawford, R., Mule, J. J. & Chamberlain, J. S. Immune evasion by muscle-specific gene expression in dystrophic muscle. Mol. Ther. 4, 525\u2013533 (2001).","journal-title":"Mol. Ther."},{"key":"7710_CR47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/104303401750061267","volume":"12","author":"L Cordier","year":"2001","unstructured":"Cordier, L. et al. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum. Gene Ther. 12, 205\u2013215 (2001).","journal-title":"Hum. Gene Ther."},{"key":"7710_CR48","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","volume":"388","author":"CG Boennemann","year":"2023","unstructured":"Boennemann, C. G. et al. Dystrophin immunity after gene therapy for Duchenne\u2019s muscular dystrophy. N. Engl. J. Med. 388, 2294\u20132296 (2023).","journal-title":"N. Engl. J. Med."},{"key":"7710_CR49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-1-4939-7374-3_18","volume":"1687","author":"CL Halbert","year":"2018","unstructured":"Halbert, C. L., Allen, J. M. & Chamberlain, J. S. AAV6 vector production and purification for muscle gene therapy. Methods Mol. Biol. 1687, 257\u2013266 (2018).","journal-title":"Methods Mol. Biol."},{"key":"7710_CR50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1014587918367","volume":"22","author":"C Dellorusso","year":"2001","unstructured":"Dellorusso, C., Crawford, R. W., Chamberlain, J. S. & Brooks, S. V. Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J. Muscle Res. Cell Motil. 22, 467\u2013475 (2001).","journal-title":"J. Muscle Res. Cell Motil."},{"key":"7710_CR51","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0002-9440(10)64502-6","volume":"161","author":"P Gregorevic","year":"2002","unstructured":"Gregorevic, P., Plant, D. R., Leeding, K. S., Bach, L. A. & Lynch, G. S. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am. J. Pathol. 161, 2263\u20132272 (2002).","journal-title":"Am. J. Pathol."},{"key":"7710_CR52","doi-asserted-by":"publisher","unstructured":"Kolwicz, S. C., Jr. & Tian, R. Assessment of cardiac function and energetics in isolated mouse hearts using 31P NMR spectroscopy. J. Vis. Exp. https:\/\/doi.org\/10.3791\/2069 (2010).","DOI":"10.3791\/2069"},{"key":"7710_CR53","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacbts.2019.06.006","volume":"4","author":"SC Kolwicz Jr.","year":"2019","unstructured":"Kolwicz, S. C. Jr. et al. Gene therapy rescues cardiac dysfunction in Duchenne muscular dystrophy mice by elevating cardiomyocyte deoxy-adenosine triphosphate. JACC Basic Transl. Sci. 4, 778\u2013791 (2019).","journal-title":"JACC Basic Transl. Sci."},{"key":"7710_CR54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.134.1.93","volume":"134","author":"JA Rafael","year":"1996","unstructured":"Rafael, J. A. et al. Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134, 93\u2013102 (1996).","journal-title":"J. Cell Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07710-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:08:18Z","timestamp":1722427698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07710-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":54,"journal-issue":{"issue":"8023","published-print":{"date-parts":[[2024,8,1]]}},"alternative-id":["7710"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-07710-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2924001\/v1","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Washington has intellectual property based on the findings of this study. J.S.C. and S.D.H. are inventors of patents covering \u2206R4-R23\/\u2206CT \u00b5Dys, \u00b5Dys5 and CK8e expression cassettes. D.G. is an inventor of a patent describing the development of the AAVMYO capsid. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}